Indication
Stage 1B Mycosis Fungoides/Sezary Syndrome
2 clinical trials
2 products
1 drug
Clinical trial
A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell TransplantStatus: Completed, Estimated PCD: 2024-02-02
Clinical trial
Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCLStatus: Active (not recruiting), Estimated PCD: 2020-08-11
Product
romidepsinDrug
lenalidomide